Sustained Effect of Travoprost on Diurnal and Nocturnal Intraocular Pressure

Arthur J Sit, Robert N. Weinreb, Jonathan G. Crowston, Daniel F. Kripke, John H K Liu

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Purpose: To assess the diurnal and nocturnal persistency of intraocular pressure (IOP) reduction after omission of up to two doses of once-daily topical travoprost in patients with open-angle glaucoma or ocular hypertension. Design: Prospective, open-label study. Methods: Twenty subjects underwent three sessions of 24-hour IOP monitoring. The first session occurred before initiating treatment of newly diagnosed patients or after a four-week washout in patients already receiving medical therapy. The second session occurred after four weeks or more of travoprost treatment. The third session was performed 41 to 63 hours after the last travoprost dose. Results: IOP lowering persisted after omission of one to two doses. Between 41 to 63 hours after the last dose, diurnal IOP reduction was attenuated, but nocturnal IOP reduction sustained. Conclusions: IOP lowering effect after omission of one to two doses of travoprost is attenuated in the diurnal period but sustained in the nocturnal period, the time corresponding to the highest baseline habitual IOP.

Original languageEnglish (US)
Pages (from-to)1131-1133
Number of pages3
JournalAmerican Journal of Ophthalmology
Volume141
Issue number6
DOIs
StatePublished - Jun 2006
Externally publishedYes

Fingerprint

Intraocular Pressure
Ocular Hypertension
Open Angle Glaucoma
Travoprost
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Sustained Effect of Travoprost on Diurnal and Nocturnal Intraocular Pressure. / Sit, Arthur J; Weinreb, Robert N.; Crowston, Jonathan G.; Kripke, Daniel F.; Liu, John H K.

In: American Journal of Ophthalmology, Vol. 141, No. 6, 06.2006, p. 1131-1133.

Research output: Contribution to journalArticle

Sit, Arthur J ; Weinreb, Robert N. ; Crowston, Jonathan G. ; Kripke, Daniel F. ; Liu, John H K. / Sustained Effect of Travoprost on Diurnal and Nocturnal Intraocular Pressure. In: American Journal of Ophthalmology. 2006 ; Vol. 141, No. 6. pp. 1131-1133.
@article{313fc606f1414b9d9ef4b0c0dce47979,
title = "Sustained Effect of Travoprost on Diurnal and Nocturnal Intraocular Pressure",
abstract = "Purpose: To assess the diurnal and nocturnal persistency of intraocular pressure (IOP) reduction after omission of up to two doses of once-daily topical travoprost in patients with open-angle glaucoma or ocular hypertension. Design: Prospective, open-label study. Methods: Twenty subjects underwent three sessions of 24-hour IOP monitoring. The first session occurred before initiating treatment of newly diagnosed patients or after a four-week washout in patients already receiving medical therapy. The second session occurred after four weeks or more of travoprost treatment. The third session was performed 41 to 63 hours after the last travoprost dose. Results: IOP lowering persisted after omission of one to two doses. Between 41 to 63 hours after the last dose, diurnal IOP reduction was attenuated, but nocturnal IOP reduction sustained. Conclusions: IOP lowering effect after omission of one to two doses of travoprost is attenuated in the diurnal period but sustained in the nocturnal period, the time corresponding to the highest baseline habitual IOP.",
author = "Sit, {Arthur J} and Weinreb, {Robert N.} and Crowston, {Jonathan G.} and Kripke, {Daniel F.} and Liu, {John H K}",
year = "2006",
month = "6",
doi = "10.1016/j.ajo.2006.01.049",
language = "English (US)",
volume = "141",
pages = "1131--1133",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Sustained Effect of Travoprost on Diurnal and Nocturnal Intraocular Pressure

AU - Sit, Arthur J

AU - Weinreb, Robert N.

AU - Crowston, Jonathan G.

AU - Kripke, Daniel F.

AU - Liu, John H K

PY - 2006/6

Y1 - 2006/6

N2 - Purpose: To assess the diurnal and nocturnal persistency of intraocular pressure (IOP) reduction after omission of up to two doses of once-daily topical travoprost in patients with open-angle glaucoma or ocular hypertension. Design: Prospective, open-label study. Methods: Twenty subjects underwent three sessions of 24-hour IOP monitoring. The first session occurred before initiating treatment of newly diagnosed patients or after a four-week washout in patients already receiving medical therapy. The second session occurred after four weeks or more of travoprost treatment. The third session was performed 41 to 63 hours after the last travoprost dose. Results: IOP lowering persisted after omission of one to two doses. Between 41 to 63 hours after the last dose, diurnal IOP reduction was attenuated, but nocturnal IOP reduction sustained. Conclusions: IOP lowering effect after omission of one to two doses of travoprost is attenuated in the diurnal period but sustained in the nocturnal period, the time corresponding to the highest baseline habitual IOP.

AB - Purpose: To assess the diurnal and nocturnal persistency of intraocular pressure (IOP) reduction after omission of up to two doses of once-daily topical travoprost in patients with open-angle glaucoma or ocular hypertension. Design: Prospective, open-label study. Methods: Twenty subjects underwent three sessions of 24-hour IOP monitoring. The first session occurred before initiating treatment of newly diagnosed patients or after a four-week washout in patients already receiving medical therapy. The second session occurred after four weeks or more of travoprost treatment. The third session was performed 41 to 63 hours after the last travoprost dose. Results: IOP lowering persisted after omission of one to two doses. Between 41 to 63 hours after the last dose, diurnal IOP reduction was attenuated, but nocturnal IOP reduction sustained. Conclusions: IOP lowering effect after omission of one to two doses of travoprost is attenuated in the diurnal period but sustained in the nocturnal period, the time corresponding to the highest baseline habitual IOP.

UR - http://www.scopus.com/inward/record.url?scp=33744784855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744784855&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2006.01.049

DO - 10.1016/j.ajo.2006.01.049

M3 - Article

C2 - 16765686

AN - SCOPUS:33744784855

VL - 141

SP - 1131

EP - 1133

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 6

ER -